title: Acne and PCOS are less frequent in women with Mayer-Rokitansky-Küster-Hauser syndrome despite a high rate of hyperandrogenemia: a cross-sectional study.
abstract: BACKGROUND
  Acne is a very common skin condition during adolescence and adulthood. Patients with uterovaginal agenesis (Mayer-Rokitansky-Küster-Hauser syndrome, MRKH) treated at the Tübingen University Center for Rare Female Genital Malformations, however, clinically appeared to be less frequently affected by acne. The etiology of MRKH syndrome remains unknown. The only known MRKH-associated mutations are located within the WNT4 gene and lead to an atypical form of MRKH syndrome associated with clinical and biochemical hyperandrogenism. Our study aimed to assess the frequency, severity, and self-evaluation of acne in MRKH patients and to correlate the clinical findings with hormone analyses.
  
  
  METHODS
  As part of a cross-sectional longterm follow-up study after laparoscopic assisted creation of a neovagina a questionnaire was sent to 149 MRKH patients aged 16-44 years comprising 26 items concerning prevalence and self-evaluation of acne, and the effects of acne on quality of life. The questionnaire was derived from one used in a former epidemiological study of acne in 4,000 women. Blood for hormone analyses was collected routinely during the clinical visit.
  
  
  RESULTS
  Fully completed, evaluable questionnaires were returned by 69/149 (46%) women. Of these respondents, 42 (60.1%) showed hyperandrogenemia without other clinical signs of virilization but only 17 (24.6%) reported acne (8 (11.6%) had physiological acne and 9 (13.0%) clinical acne) and only 10 (14.5%) reported receiving medical treatment for their acne. Effects of acne on quality of life were minor. Only 4 patients (5.8%) with PCOS were identified, among them one with physiological acne, the other three within the acne-free group.
  
  
  CONCLUSIONS
  Although hyperandrogenemia is common, acne is significantly less frequent in women with MRKH than reported in the literature for non-MRKH women, and is seldom treated medically. Patients in this study appeared resistant to acne to some extent, possibly due to the sebaceous glands in the acne regions being less sensitive to androgens compared to the normal population. A WNT4 mutation is unlikely to be the main cause of MRKH syndrome in our hyperandrogenemic patients.
authors.affiliation: Department of Obstetrics and Gynecology, Tübingen University Hospital, Calwerstrasse 7, 72076 Tübingen, Germany. katharina.rall@med.uni-tuebingen.de.
authors.forename: Katharina
authors.initials: K
authors.lastname: Rall
authors.forename: Gabriele
authors.initials: G
authors.lastname: Conzelmann
authors.forename: Norbert
authors.initials: N
authors.lastname: Schäffeler
authors.forename: Melanie
authors.initials: M
authors.lastname: Henes
authors.forename: Diethelm
authors.initials: D
authors.lastname: Wallwiener
authors.forename: Matthias
authors.initials: M
authors.lastname: Möhrle
authors.forename: Sara Y
authors.initials: SY
authors.lastname: Brucker
mesh_terms: D058489:46, XX Disorders of Sex Development / Q000175:diagnosis / Q000453:epidemiology*; D000152:Acne Vulgaris / Q000175:diagnosis / Q000453:epidemiology*; D000293:Adolescent; D000328:Adult; D000013:Congenital Abnormalities / Q000175:diagnosis / Q000453:epidemiology*; D003430:Cross-Sectional Studies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D017588:Hyperandrogenism / Q000175:diagnosis / Q000453:epidemiology*; D015994:Incidence; D009095:Mullerian Ducts / Q000002:abnormalities*; D011085:Polycystic Ovary Syndrome / Q000175:diagnosis / Q000453:epidemiology*; D011795:Surveys and Questionnaires; D055815:Young Adult